| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G
| Fairmount Funds Management LLC reports a 6.2% stake in SOLENO THERAPEUTICS, INC. |
| 08/10/2023 |
SC 13G
| Fairmount Funds Management LLC reports a 6.1% stake in Kiniksa Pharmaceuticals, Ltd. |
| 07/21/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/07/2023 |
SC 13G
| Fairmount Funds Management LLC reports a 5% stake in AXSOME THERAPEUTICS, INC. |
| 06/30/2023 |
SC 13D
| Fairmount Funds Management LLC reports a 20% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 04/27/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 7.7% stake in ANNEXON, INC. |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 4.6% stake in AXSOME THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 6.9% stake in Astria Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 0% stake in Olema Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 5.5% stake in NUVALENT, INC. |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 9.9% stake in Terns Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 9.9% stake in TREVI THERAPEUTICS, INC. |
| 11/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/25/2022 |
SC 13G
| Fairmount Funds Management LLC reports a 5.4% stake in AXSOME THERAPEUTICS, INC. |
| 08/25/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/19/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/21/2022 |
SC 13G
| Fairmount Funds Management LLC reports a 9.9% stake in TREVI THERAPEUTICS, INC. |
| 04/21/2022 |
SC 13G
| Fairmount Funds Management LLC reports a 6.7% stake in ANNEXON, INC. |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/23/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/22/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/05/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/09/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |